146 related articles for article (PubMed ID: 14980746)
1. Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements.
Vangeneugden T; Laenen A; Geys H; Renard D; Molenberghs G
Control Clin Trials; 2004 Feb; 25(1):13-30. PubMed ID: 14980746
[TBL] [Abstract][Full Text] [Related]
2. Generalized reliability estimation using repeated measurements.
Laenen A; Vangeneugden T; Geys H; Molenberghs G
Br J Math Stat Psychol; 2006 May; 59(Pt 1):113-31. PubMed ID: 16709282
[TBL] [Abstract][Full Text] [Related]
3. Applying concepts of generalizability theory on clinical trial data to investigate sources of variation and their impact on reliability.
Vangeneugden T; Laenen A; Geys H; Renard D; Molenberghs G
Biometrics; 2005 Mar; 61(1):295-304. PubMed ID: 15737106
[TBL] [Abstract][Full Text] [Related]
4. Estimating reliability and generalizability from hierarchical biomedical data.
Molenberghs G; Laenen A; Vangeneugden T
J Biopharm Stat; 2007; 17(4):595-627. PubMed ID: 17613644
[TBL] [Abstract][Full Text] [Related]
5. An autoregressive linear mixed effects model for the analysis of longitudinal data which include dropouts and show profiles approaching asymptotes.
Funatogawa T; Funatogawa I; Takeuchi M
Stat Med; 2008 Dec; 27(30):6351-66. PubMed ID: 18767204
[TBL] [Abstract][Full Text] [Related]
6. Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: canonical correlation approach.
Alonso A; Geys H; Molenberghs G; Kenward MG; Vangeneugden T
Biometrics; 2004 Dec; 60(4):845-53. PubMed ID: 15606404
[TBL] [Abstract][Full Text] [Related]
7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
8. Measuring explained variation in linear mixed effects models.
Xu R
Stat Med; 2003 Nov; 22(22):3527-41. PubMed ID: 14601017
[TBL] [Abstract][Full Text] [Related]
9. The impact of a misspecified random-effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed models.
Litière S; Alonso A; Molenberghs G
Stat Med; 2008 Jul; 27(16):3125-44. PubMed ID: 18069726
[TBL] [Abstract][Full Text] [Related]
10. Testing for misspecification in generalized linear mixed models.
Abad AA; Litière S; Molenberghs G
Biostatistics; 2010 Oct; 11(4):771-86. PubMed ID: 20407039
[TBL] [Abstract][Full Text] [Related]
11. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Byerly MJ; Nakonezny PA; Rush AJ
Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
[TBL] [Abstract][Full Text] [Related]
12. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Amiri A; Noorbala AA; Nejatisafa AA; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Hajiazim M; Raznahan M; Akhondzadeh S
Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359
[TBL] [Abstract][Full Text] [Related]
14. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
16. Summarizing data through a piecewise linear growth curve model.
Chandrasekaran V; Gopal G; Thomas A
Stat Med; 2005 Apr; 24(8):1139-51. PubMed ID: 15568186
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
19. Alternative methods to evaluate trial level surrogacy.
Abrahantes JC; Shkedy Z; Molenberghs G
Clin Trials; 2008; 5(3):194-208. PubMed ID: 18559408
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
Mishara AL; Goldberg TE
Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
